Mikuláš Hrubiško, MD

Professor
Clinic of Hematology and Transfusiology, Slovak Medical University, University Hospital Bratislava, Slovakia

N/A

Poster(s):

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial